Common Side Effects: Clinical trials involving approximately 900 participants indicate that AOD-9604 is generally well-tolerated with a favorable safety profile
Injection Technique General subcutaneous technique, following established clinical best-practice guidance [10] [11]
Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 192 million participants (in Eng)
If international shipping becomes available, well announce it on our website
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
What learners say The training was easy to follow, professionally presented, and useful for building confidence before the next practical step. Sophie H., facial aesthetics practitioner Frequently asked questions What this course is - and what it is not This is online theory training with a certificate on completion
